Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.

Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.

Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.

New search

Natural Product Number (NPN):

80114348

Market status:

Not Marketed

Licence Status:

Active

Brand name(s):

PelaForce

Licence holder:

B Ingredients Inc.

Dosage Form:

Capsule

Recommended route of administration:

Oral

Recommended use or purpose:

Helps to reduce/relieve the symptoms of upper respiratory tract infections (e.g., common colds). Helps to provide(s) symptomatic relief from/reduce(s) symptom severity of bronchitis, laryngitis, pharyngitis, and/or the common cold (in children, adolescents, and/or adults). Helps to relieve(s) symptoms (of cough, runny nose, sore throat, sputum, and/or chest pain from coughing) associated with bronchitis, laryngitis, pharyngitis, and/or the common cold (in children, adolescents, and/or adults). Helps to reduce the recovery time from/duration of bronchitis, laryngitis, pharyngitis, and/or the common cold (in children, adolescents, and/or adults). Helps to reduce/relieve the symptoms associated with bronchitis and upper respiratory tract infections (e.g., common colds). Helps to reduce/relieve the symptoms (cough, runny nose, sore throat, sputum, and/or chest pain from coughing) associated with upper respiratory tract infections (e.g., common colds).

Risk Information:

Cautions and Warnings 

If you have a liver disorder, consult a health care practitioner prior to use. Stop use if you develop symptoms of liver trouble such as yellowing of the skin/eyes (jaundice), stomach pain, dark urine, sweating, nausea, unusual tiredness and/or loss of appetite and consult a health care practitioner. Consult a health care practitioner if symptoms persist or worsen. If symptoms are severe or are accompanied by high fever and shortness of breath, consult a health care practitioner.

Contra-Indications 

Do not use if you are pregnant or breastfeeding.

Known Adverse Reactions 

Some people may experience gastrointestinal discomfort. In rare cases, some people may experience mild nosebleeds or may experience bleeding gums. Hypersensitivity, such as an allergy, has been known to occur; in which case, discontinue use. Rare, unpredictable cases of liver injury have been reported.

List of medicinal ingredients:

Medicinal ingredients	Quantity (Qty)	Extract	Potency
Pelargonium sidoides	20.0 mg	10.000 : 1 DHE: 200 mg Dry

List of non-medicinal ingredients:

• Hypromellose
• Magnesium stearate

Date of licensing:

2021-11-22

Revised date of licence:

2023-02-22